Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 75/100

Failure Rate

20.0%

6 terminated/withdrawn out of 30 trials

Success Rate

72.7%

-13.8% vs industry average

Late-Stage Pipeline

3%

1 trials in Phase 3/4

Results Transparency

0%

0 of 16 completed trials have results

Key Signals

4 recruiting6 terminated

Enrollment Performance

Analytics

N/A
9(34.6%)
Phase 2
8(30.8%)
Phase 1
7(26.9%)
Phase 3
1(3.8%)
Early Phase 1
1(3.8%)
26Total
N/A(9)
Phase 2(8)
Phase 1(7)
Phase 3(1)
+1 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (30)

Showing 20 of 30 trials
NCT05208710Early Phase 1Recruiting

PANHPVAX, Study of a New HPV Vaccine in Healthy Volunteers

Role: collaborator

NCT03396718Not ApplicableRecruiting

De-escalation of Adjuvant Radio (Chemo) Therapy for HPV-positive Head-neck Squamous Cell Carcinomas

Role: collaborator

NCT07153289Phase 1Not Yet Recruiting

CD318-targeted CAR-T Cell Therapy in Patients With Pancreatic Cancer (ResCPa)

Role: collaborator

NCT05690048Phase 2Recruiting

Fecal Microbiota Transfer in Liver Cancer to Overcome Resistance to Atezolizumab/Bevacizumab (FLORA)

Role: collaborator

NCT05448573Active Not Recruiting

A Longitudinal Study to Investigate and Develop a Patient-centered and Effective Fatigue Screening

Role: collaborator

NCT03127215Phase 2Completed

Study of Olaparib/Trabectedin vs. Doctor's Choice in Solid Tumors

Role: lead

NCT03158389Phase 1Completed

NCT Neuro Master Match - N²M² (NOA-20)

Role: collaborator

NCT04173585Phase 2Completed

TEAM-Trial: Targeting Epigenetic Therapy Resistance in AML With Bortezomib

Role: collaborator

NCT02678832Completed

Momentum Project Heidelberg - Dealing Actively With a Cancerous Disease

Role: collaborator

NCT05606588Not ApplicableRecruiting

Preventing Sensory and Motor Dysfunctions in Children Receiving Neurotoxic Chemotherapy

Role: collaborator

NCT02679677Not ApplicableCompleted

Evaluation of the Effects of Whole Body Vibration on the Lung Function of Patients With Stable COPD

Role: collaborator

NCT04252248Phase 1Terminated

Decitabine Treatment in HPV-Induced Anogenital and Head and Neck Cancer Patients After Radiotherapy or as Novel Late Salvage

Role: collaborator

NCT02871284Not ApplicableCompleted

Prevention of Chemotherapy-Related Polyneuropathy Via Sensorimotor Exercise Training

Role: collaborator

NCT01374399Not ApplicableCompleted

Physical Exercise Therapy vs Relaxation in Allogeneic Stem Cell Transplantation (PETRA)

Role: collaborator

NCT02310243Phase 1Unknown

Study of Palbociclib in MLL-rearranged Acute Leukemias

Role: collaborator

NCT02454634Phase 1Completed

Phase I Trial of IDH1 Peptide Vaccine in IDH1R132H-mutated Grade III-IV Gliomas

Role: lead

NCT02055508Not ApplicableCompleted

POSITIVE - Study (Part III) Heidelberg

Role: collaborator

NCT03210285Completed

WES of NF2-associated in Comparison to Sporadic Vestibular Schwannomas - Correlation With Clinical Data

Role: collaborator

NCT01422499Phase 1Completed

Vorinostat in Children

Role: lead

NCT02577588Phase 1Terminated

Trial of Adoptive T Cell Therapy With Activated P53 Specific T Cells for Treatment of Advanced Colorectal Cancer

Role: lead